Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fpubh.2026.1966902.s001ObjectivesRedLabRA is a network of microbiology laboratories for the genomic surveillance of antibiotic resistance. The aim of this study was to describe the actions undertaken by RedLabRA in response to an increase of vancomycin-resistant enterococci (VRE) in some Spanish regions.MethodsRedLabRA designed a VRE surveillance organized in two phases: (1) a questionnaire to assess risk perception of VRE among the network’s Level 2 laboratories (LN2), and (2) collection of cases detected between April 2023 and March 2024, followed by WGS of a sample of vancomycin-resistant Enterococcus faecium (VREfm) isolates to investigate interregional dissemination. WGS was performed using the Illumina platform; MLST (PubMLST.org scheme), cgMLST and phylogenetic relationships (Ridom SeqSphere+ v3.5.0), and resistome (Resfinder 4.7.2) were analysed.ResultsNine of the 17 autonomous communities defined a priority scenario of VRE. 31 LN2 reported 1,958 VRE cases from 86 hospitals across 12 autonomous communities and the autonomous city Ceuta. The predominant species was E. faecium (97.1%). 317 VREfm isolates were included for WGS: 211 (66.6%) carried the vanA gene, 90 (28.4%) vanB, and 16 (5%) both genes. ST117 (34.7%), ST80 (27.1%), or ST1421 (25.6%) predominated. Using cgMLST (1,423 genes, cutoff of 5 alleles), 45 VREfm clusters were identified, of which eight involved at least three hospitals and were inter-regional. 51 (16.1%) isolates carried linezolid resistance mechanisms, mainly optrA+cfrD.ConclusionVREfm had a highly uneven impact across Spanish regions. The inter-regional presence of VREfm isolates with high genetic similarity belonging to ST1421, ST117, and ST80 clones was detected. The emergence of E. faecium isolates carrying genes conferring resistance to vancomycin and linezolid requires ongoing surveillance.
Keyword(s):
enterococci; Enterococcus faecalis; Enterococcus faecium; linezolid; Public Health and Health Services not elsewhere classified.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)